
UB842
ProductOmeprazole and Sodium Bicarbonate Capsules
StrengthEach capsule contains omeprazole 20mg and sodium bicarbonate 1100mg
IndicationsGastric ulcer; Duodenal ulcer; Gastrooesophageal reflux disease; Zollinger-Ellison syndrome
TherapeuticsGastroenterology & Hepatology
GMPCN - NMPA
RegistrationChina
ModalitiesSmall Molecule
Exclusive Summary
- Differentiated Immediate-Release Profile: The addition of sodium bicarbonate enables rapid omeprazole absorption, providing significantly faster relief than traditional delayed-release capsules and controlling nocturnal acid breakthrough.
- Favorable Competitive Landscape: Unlike the heavily saturated plain omeprazole market, this combination has higher formulation barriers and fewer generic competitors, protecting distributors from severe price wars.
- Massive Market Demand: Driven by a global GERD prevalence of 13-19% and hundreds of millions of patients reliably continuously demanding highly effective PPI therapies.
- Overwhelming Cost Advantage: Leveraging China's vertically integrated API-formulation supply chain ensures highly competitive pricing, guaranteeing lucrative profit margins for overseas distributors.
我们能如何帮助您?
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →